Search results
Aileron Therapeutics Shelves Development On Chemoprotection Agent, Shares Fall
Benzinga via Yahoo Finance· 1 year agoAileron Therapeutics (NASDAQ: ALRN) announced that a review of initial data from its Phase 1b...
Aileron Therapeutics (NASDAQ: ALRN) announced that a review of initial data from its Phase 1b...